Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
22.75
+1.41 (6.58%)
At close: Oct 15, 2026, 4:00 PM EDT
22.88
+0.13 (0.59%)
After-hours: Oct 15, 2026, 7:36 PM EDT
Fortrea Holdings Market Cap
Fortrea Holdings has a market cap or net worth of $2.16 billion as of October 15, 2026. It is the 6,330th most valuable company in the world and the 1,716th biggest in the United States. Its market cap has increased by 149.45% in one year.
Market Cap
2.16B
Enterprise Value
3.11B
1-Year Change
149.45%
Global Rank
Country Rank
#1,716 United States
Category
ChartMarket Cap Chart
Since June 16, 2023, Fortrea Holdings's market cap has decreased from $2.67B to $2.16B, a decrease of -18.89%. That is a compound annual growth rate of -6.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 2.16B | 35.71% |
| Dec 31, 2025 | 1.59B | -4.72% |
| Dec 31, 2024 | 1.67B | -46.02% |
| Dec 29, 2023 | 3.10B | 16.21% |
| Jun 16, 2023 | 2.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 2.29B |
| Celldex Therapeutics | 2.27B |
| Recursion Pharmaceuticals | 2.23B |
| Harmony Biosciences Holdings | 2.23B |
| Aurinia Pharmaceuticals | 2.23B |
| Viridian Therapeutics | 2.22B |
| Disc Medicine | 2.17B |
| Novavax | 2.11B |